Transfusion Medicine Reviews
Volume 24, Issue 1 , Pages 33-43 , January 2010

In Vitro Megakaryocyte Production and Platelet Biogenesis: State of the Art

References 

  1. Long MW, Hoffman R. In Thrombocytopoiesis. In: Hematology Basic Principles and Practice. ed 3. USA: Churchill Livingstone; 2000;p. 245–260
  2. Battinelli EM, Hartwig JH, Italiano JE. Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis. Curr Opin Hematol. 2007;14:419–426
  3. Vitrat N, Cohen-Solal K, Pique C, et al. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood. 1998;91:3711–3723
  4. Lordier L, Jalil A, Aurade F, et al. Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood. 2008;112:3164–3174
  5. Kaufman RM, Airo R, Pollack S, et al. Circulating megakaryocytes and platelet release in the lung. Blood. 1965;26:720–731
  6. Italiano JE, Shivdasani RA. Megakaryocytes and beyond: The birth of platelets. J Thromb Haemost. 2003;1:1174–1182
  7. Becker RP, De Bruyn PP. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation: A scanning electron microscopic investigation. Am J Anat. 1976;145:183–205
  8. Junt T, Schulze H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science. 2007;317:1767–1770
  9. De Botton S, Sabri S, Daugas E, et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood. 2002;100:1310–1317
  10. Clarke MC, Savill J, Jones DB, et al. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J Cell Biol. 2003;160:577–587
  11. Zucker-Franklin D, Philipp CS. Platelet production in the pulmonary capillary bed: New ultrastructural evidence for an old concept. Am J Pathol. 2000;157:69–74
  12. Zucker-Franklin D, Petursson S. Thrombocytopoiesis—Analysis by membrane tracer and freeze-fracture studies on fresh human and cultured mouse megakaryocytes. J Cell Biol. 1984;99:390–402
  13. Kosaki G. In vivo platelet production from mature megakaryocytes: Does platelet release occur via proplatelets?. Int J Hematol. 2005;81:208–219
  14. Bertolini F, Battaglia M, Pedrazzoli P, et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood. 1997;89:2679–2688
  15. Mazur EM, Basilico D, Newton JL, et al. Isolation of large numbers of enriched human megakaryocytes from liquid cultures of normal peripheral blood progenitor cells. Blood. 1990;76:1771–1782
  16. Teramura M, Katahira J, Hoshino , et al. Clonal growth of human megakaryocyte progenitors in serum-free cultures: Effect of recombinant human interleukin 3. Exp Hematol. 1988;16:843–848
  17. Bruno E, Hoffman R. Effect of interleukin 6 on in vitro human megakaryocytopoiesis: Its interaction with other cytokines. Exp Hematol. 1989;17:1038–1043
  18. Guerriero R, Testa U, Gabbianelli M, et al. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood. 1995;86:3725–3736
  19. Tao H, Gaudry L, Rice A, et al. Cord blood is better than bone marrow for generating megakaryocytic progenitor cells. Exp Hematol. 1999;27:293–301
  20. Shim MH, Hoover A, Blake N, et al. Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol. 2004;32:638–648
  21. De Bruyn C, Delforge A, Martiat P, et al. Ex vivo expansion of megakaryocyte progenitor cells: Cord blood versus mobilized peripheral blood. Stem Cells Dev. 2005;14:415–424
  22. Su RJ, Li K, Yang M, et al. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood. Bone Marrow Transplant. 2001;27:1075–1080
  23. Proulx C, Boyer L, Hurnanen DR, et al. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. J Hematother Stem Cell Res. 2003;12:179–188
  24. Bruno S, Gunetti M, Gammaitoni L, et al. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: Rapid and transient megakaryocyte reconstitution. Haematologica. 2003;88:379–387
  25. Sun SY, Reems JA. Large scale production of megakaryocytes. Exp Hematol [manuscript in preparation].
  26. Gaur M, Kamata T, Wang S, et al. Megakaryocytes derived from human embryonic stem cells: A genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost. 2006;4:436–442
  27. Choi ES, Nichol JL, Hokom MM, et al. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood. 1995;85:402–413
  28. Debili N, Wendling F, Katz A, et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 1995;86:2516–2525
  29. Cramer EM, Norol F, Guichard J, et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood. 1997;89:2336–2346
  30. Fujimoto TT, Kohata S, Suzuki H, et al. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood. 2003;102:4044–4051
  31. Takayama N, Nishikii H, Usui J, et al. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood. 2008;111:5298–5306
  32. Nishikii H, Eto K, Tamura N, et al. Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells. J Exp Med. 2008;205:1917–1927
  33. Norol F, Vitrat N, Cramer E, et al. Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood. 1998;91:830–843
  34. Sun L, Tan P, Yap C, et al. In vitro biological characteristics of human cord blood-derived megakaryocytes. Ann Acad Med Singapore. 2004;33:570–575
  35. Ungerer M, Peluso M, Gillitzer A, et al. Generation of functional culture-derived platelets from CD34+ progenitor cells to study transgenes in the platelet environment. Circ Res. 2004;95:e36–e44
  36. Matsunaga T, Tanaka I, Kobune M, et al. Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells. 2006;24:2877–2887
  37. Sullenbarger B, Bahng JH, Gruner R, et al. Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol. 2009;37:101–110
  38. Gandhi MJ, Drachman JG, Reems JA, et al. A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells. Blood Cells Mol Dis. 2005;35:70–73
  39. Robert A, Boyer, Lucie, Pineault, N. Glycoprotein Iba receptor integrity is essential for functional properties of platelet-like particles produced from cord blood CD34+ enriched cells in liquid culture [submitted for publication].
  40. Choi ES, Hokom M, Bartley T, et al. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. Stem Cells. 1995;13:317–322
  41. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev. 1997;11:130–144
  42. Bergmeier W, Piffath CL, Cheng G, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res. 2004;95:677–683
  43. Rabie T, Strehl A, Ludwig A, et al. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem. 2005;280:14462–14468
  44. Kehrel B, Wierwille S, Clemetson KJ, et al. Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood. 1998;91:491–499
  45. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227–1234
  46. Bergmeier W, Burger PC, Piffath CL, et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro–aged or –injured mouse platelets. Blood. 2003;102:4229–4235
  47. Bornstein R, Garcia-Vela J, Gilsanz F, et al. Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. Br J Haematol. 2001;114:458–465
  48. van den Oudenrijn S, von dem Borne AE, de Haas M. Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol. 2000;28:1054–1061
  49. Mattia G, Vulcano F, Milazzo L, et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood. 2002;99:888–897
  50. Miyazaki R, Ogata H, Iguchi T, et al. Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haematol. 2000;108:602–609
  51. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676
  52. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–1920
  53. Gurney AL, Carver-Moore K, de Sauvage FJ, et al. Thrombocytopenia in c-mpl–deficient mice. Science. 1994;265:1445–1447
  54. Alexander WS, Roberts AW, Nicola NA, et al. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood. 1996;87:2162–2170
  55. Kaushansky K, Broudy V, Lin N, et al. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A. 1995;92:3234–3238
  56. Kaushansky K. Thrombopoietin: The primary regulator of platelet production. Blood. 1995;86:419–431
  57. Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994;369:565–568
  58. Kaushansky K. Thrombopoietin and hematopoietic stem cell development. Ann N Y Acad Sci. 1999;872:314–319
  59. Drachman JG. Role of thrombopoietin in hematopoietic stem cell and progenitor regulation. Curr Opin Hematol. 2000;7:183–190
  60. Dolzhanskiy A, Basch RS, Karpatkin S. The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3. Blood. 1997;89:426–434
  61. Schattner M, Lefebvre P, Mingolelli SS, et al. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells. 1996;14:207–214
  62. Cortin V, Garnier A, Pineault N, et al. Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol. 2005;33:1182–1191
  63. Fujiki H, Kimura T, Minamiguchi H, et al. Role of human interleukin-9 as a megakaryocyte potentiator in culture. Exp Hematol. 2002;30:1373–1380
  64. Feng Y, Zhang L, Xiao ZJ, et al. An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11. Exp Hematol. 2005;33:1537–1543
  65. Shaw PH, Gilligan D, Wang XM, et al. Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system. Biol Blood Marrow Transplant. 2003;9:151–156
  66. Sigurjonsson OE, Gudmundsson KO, Haraldsdottir V, et al. Flt3/Flk-2 ligand in combination with thrombopoietin decreases apoptosis in megakaryocyte development. Stem Cells Dev. 2004;13:183–191
  67. Sitnicka E, Lin N, Priestley GV, et al. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood. 1996;87:4998–5005
  68. Kobayashi M, Laver JH, Kato T, et al. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood. 1996;88:429–436
  69. Piacibello W, Sanavio F, Severino A, et al. Ex vivo expansion of cord blood progenitors. Vox Sang. 1998;74:457–462
  70. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004;10:64–71
  71. Majka M, Baj-Krzyworzeka M, Kijowski J, et al. In vitro expansion of human megakaryocytes as a tool for studying megakaryocytic development and function. Platelets. 2001;12:325–332
  72. Mazur EM, Cohen JL, Newton J, et al. Human serum megakaryocyte colony-stimulating activity appears to be distinct from interleukin-3, granulocyte-macrophage colony-stimulating factor, and lymphocyte-conditioned medium. Blood. 1990;76:290–297
  73. Gewirtz AM, Calabretta B, Rucinski B, et al. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest. 1989;83:1477–1486
  74. Griffin CG, Grant BW. Effects of recombinant interferons on human megakaryocyte growth. Exp Hematol. 1990;18:1013–1018
  75. Fukushima-Shintani M, Suzuki K, Iwatsuki Y, et al. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis. Exp Hematol. 2008;36:1337–1342
  76. Broudy VC, Lin NL. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine. 2004;25:52–60
  77. Wei MX, Yang Y, Ge YC, et al. Functional characterization of hNUDC as a novel accumulator that specifically acts on in vitro megakaryocytopoiesis and in vivo platelet production. J Cell Biochem. 2006;98:429–439
  78. Lannutti BJ, Blake N, Gandhi MJ, et al. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood. 2005;105:3875–3878
  79. Han P, Guo XH, Story CJ. Enhanced expansion and maturation of megakaryocytic progenitors by fibronectin. Cytotherapy. 2002;4:277–283
  80. Verfaillie CM. Adhesion receptors as regulators of the hematopoietic process. Blood. 1998;92:2609–2612
  81. Rafii S, Shapiro F, Pettengell R, et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood. 1995;86:3353–3363
  82. Schattner M, Green D, Cohen I. Stromal-conditioned medium synergizes with thrombopoietin in stimulating megakaryocytopoiesis. Stem Cells. 1998;16:61–65
  83. LaIuppa JA, Papoutsakis ET, Miller WM. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol. 1998;26:835–843
  84. Mostafa SS, Miller WM, Papoutsakis ET. Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol. 2000;111:879–889
  85. Mostafa SS, Papoutsakis ET, Miller WM. Oxygen tension modulates the expression of cytokine receptors, transcription factors, and lineage-specific markers in cultured human megakaryocytes. Exp Hematol. 2001;29:873–883
  86. Yang H, Miller WM, Papoutsakis ET. Higher pH promotes megakaryocytic maturation and apoptosis. Stem Cells. 2002;20:320–328
  87. Proulx C, Dupuis N, St-Amour I, et al. Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C. Biotechnol Bioeng. 2004;88:675–680
  88. Pineault N, Boucher JF, Cayer MP, et al. Characterization of the effects and potential mechanisms leading to increased megakaryocytic differentiation under mild hyperthermia. Stem Cells Dev. 2008;17:483–493
  89. Scurfield G, Radley JM. Aspects of platelet formation and release. Am J Hematol. 1981;10:285–296
  90. Hagiwara T, Nagasawa T, Nagahisa H, et al. Expression of adhesion molecules on cytoplasmic processes of human megakaryocytes. Exp Hematol. 1996;24:690–695
  91. Dunois-Larde C, Capron C, Fichelson S, et al. Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood. 2009;[Epub ahead of print]

 This work was supported in part by the Puget Sound Blood Center and NIH grant P50 HL081015.

PII: S0887-7963(09)00083-2

doi: 10.1016/j.tmrv.2009.09.003

Transfusion Medicine Reviews
Volume 24, Issue 1 , Pages 33-43 , January 2010

Article Tools

* Image Usage & Resolution